0.110 (0.0%)

T-O: 0.0 (08:59:00)
Last updated: 17:00

Fundamental   0.8  
Technical   3.3  
Total Score   4.1  

 Sector Trend+   Negative Earnings- 


iSaham Fundamental Trend

FCON: 0.43 | Sharpe Ratio: -0.0 | LTS: 4.3

Quarter Reports

Trailing Dividend

Financial Ratios

EPS -3.94 sen
Trailing PE (Sector Median: 17.3) 0.0
Altman Z 1.9
Beaver -0.357
Current Ratio 5.13
Debt-Equity (DE) Ratio 0.32
FCF Yield -25.0 %
Dividend Per Share (DPS) 0.0 sen
Revenue QoQ -68.11 %
Revenue YoY -33.4 %
Profit QoQ -167.22 %
Profit YoY -179.44 %
NTA QoQ -15.0 %
Profit Margin (Sector Median: 2.5) -10.51 %
ROE -19.95 %
ROIC -17.28 %
Dividend Yield (DY) 0.0 %

Fair Value

iSaham Fair Value: -0.245

Discounted Cash Flow (DCF)5.0% Growth -0.315
Discounted Cash Flow (DCF)-45.6% Growth -0.245
Relative Valuation 0.0
Graham Formula -0.26
Graham Number 0.0
Net Tangible Asset (NTA) 0.17

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0.0
Expected Revenue (M) 0.0
Expected Growth (%) 0.0



Market Cap: 57 M.

Number of Shares: 525 M.

Float: Not Available.

Stock highly correlated with

SENDAI (91%)

UNISEM (91%)

ELSOFT (90%)


The principal activities of Sunzen Biotech Berhad are investment holding and manufacturing of animal health products. The principal activities of the subsidiaries are R&D; and commercialisation of in-feed anti bacterial products and supplements for animal health products, distribution amd marketing of animal health products. Sunzen Biotech Berhad was incorporated in Malaysia on 8 February 2005 as a public limited company. The group consists of Sunzen Biotech and wholly owned subsidiaries namely Sunzen Corporation, Sunzen LifeSciences and Sunzen Feedtech. The principle activities of the company is investment holding whilst it subsidiaries are involved in the manufacturing of animal health products focused in animal feed additive market to feed millers and livestock producers across Asian markets. The company manufactures and distributes its own brand of products mainly locally.

Sectors: Penny Stocks, Healthcare, Agricultural Products, Consumer Products & Services

Code: 0148


Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 28-Mar-2019

Shareholder Value (M)
Maybank Kim Eng Securities Pte Ltd 5.69
Lim Eng Chai 0.79
Low Hoi Pin 0.58
Tan Ah Lin 0.45
Teow Mooi Leng 0.4
Teow Chee Chow 0.38
Tan Kim Hee 0.35
Wong Pei Fern 0.27
Kwan Choon Ling 0.26
Kok Poe Chu 0.26
Nyong Chye Seng 0.24
Lim Gim Leong 0.24
Looi Ai Woon 0.24
Low Han Pial 0.23
Ng Chee Chau 0.23
Yeow Lye Meng 0.19
Oh Chee Kiong 0.15
Ho Han Suah 0.15
Lim Lay Hiang 0.14
Ooi Bee Hoon 0.13
Lim Tong Liam 0.13
Lim Poh Chuw 0.13
Tan Boon Yew 0.13
Ooi Lay Kim 0.11
Ong Chai Lun 0.11
Teh Ling Ling 0.11
Chew Boon Kian 0.11
Cheong Heok Boo 0.11
Wee Huat Kiap 0.11
Tan Chee Hiang 0.11